Novye formy topicheskikh dekongestantov v lechenii ostrogo vospaleniya slizistoy obolochki nosa


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The article considers the problem of acute rhinitis (AR), in which most common cause is a viral infection. Pathogenic mechanisms of AR associated with the violation of the ciliated epithelium and depression of mechanisms of local protection of upper respiratory tract are discussed. In AR, given the morphological and functional disorders in the nasal cavity and the clinical manifestations of the disease (nasal obstruction, rhinorrhea), the use of decongestants for rapid reduction of swelling, restoration of patency of the nasal passages and improvement of nasal breathing, is appropriate and pathogenetically justified component of treatment.

全文:

受限制的访问

参考

  1. Онищенко Г.Г. Эпидемическая обстановка в Российской Федерации и основные направления деятельности по ее стабилизации. М., 2002. С. 24-5.
  2. Савлевич Е.Л. Применение современного назального спрея СНУП с морской водой лечения в оториноларингологии". М., 2011. С. 612-3.
  3. Deitmer T., Scheffler R. The effect of different preparations of nasal decongestants in ciliary beat frequency in vitro. Rhinology 1993;31:151-53.
  4. Freeman B. Free radical chemistry of nitric oxide: Looking at the dark side. Chest 1994;84.
  5. Hanazawa T., et al. Nitric oxide synthase-immunoreactive nerve fibers in the nasal mucosa of the rat. Brain Res 1994;19,657(1-2):7-13.
  6. Kai T. Effects of topical alpha 1- and beta 2-adrenoceptor stimulants on nasal nitric oxide level. Nippon Jibiinkoka Gakkai Kaiho 1999;102(7):898-906.
  7. Кюлев А.И. Ирригационная терапия верхних дыхательных путей. М., 1987.
  8. Papsin B., McTavish A. Saline nasal irrigation: Its role as an adjunct treatment. Can Fam Physician 2003;9:168-73.
  9. Pasto M., Serrano E., Urocoste E., et al. Nasal polyp-derived superoxide anion: dose-dependent inhibition by nitric oxide and pathophysiological implications. Am J Respir Crit Care Med 2001;163(1):145-51.
  10. Tuettenberg A., Koelsch S., Knop J., Jonuleit H. Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cells. Exp Dermatol 2007; 16(3):171-78.
  11. Riederer A., Held B., Mack B. Immunohistochemical study of the distribution of constitutive nitric oxide synthase in vascular endothelium of the nasal mucosa in the human. Laryngorhinootologie 1999;78(7):373-77.
  12. Rudack C., Bachert C. Cytokines and chemokines in paranasal sinus diseases. Laryngorhinootologie 1999;78(9):481-90.
  13. Ruuskanen O., Heikkinen T. Upper respiratory tract infectnion. Encyclopedia of respiratory medicine. Eds: Laurent GL, Shapiro SD. 3. Oxford, UK Academic Press - 2006; 4:385-89.
  14. Schlosser R.J., Spotnitz W.D., Peters E.J., et al. Elevated nitric oxide metabolite levels in chronic sinusitis. Otolaryngol Head Neck Surg 2000;123(4):357-62.
  15. Taverner D., Latte J. Nasal decongestants for the common cold. Cochrane Database Syst Rev 2007;1:CD001953.
  16. Westerveld G.J., Voss H.P., van der Hee R.M. !nhibition of nitric oxide synthase by nasal decongestants. Eur Respir J 2000; 16(3);437-44.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##